Vagus nerve and carotid baroreceptor stimulation system

US11918812B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-11918812-B2
Application numberUS-202016854054-A
CountryUS
Kind codeB2
Filing dateApr 21, 2020
Priority dateAug 12, 2014
Publication dateMar 5, 2024
Grant dateMar 5, 2024

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Systems and methods are provided for delivering vagus nerve stimulation and carotid baroreceptor stimulation to patients for treating chronic heart failure and hypertension. The vagus nerve stimulation and carotid baroreceptor stimulation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies.

First claim

Opening claim text (preview).

What is claimed is: 1. A method of operating an implantable neurostimulation system, comprising: delivering a carotid baroreceptor stimulation (CBS) therapy to carotid baroreceptors of a patient for a treatment of chronic heart failure, according to a set of parameters, with a pulse generator via a CBS electrode assembly having at least one CBS electrode contact and an integrated pressure sensor configured to sense a blood pressure of the patient, the at least one CBS electrode contact and the integrated pressure sensor integrated into a single cuff structure; determining an activity level of the patient based on the sensed blood pressure of the patient; and modifying the set of parameters of the CBS therapy based on the determined activity level, wherein, in a first activity level state, the CBS therapy is delivered at a first intensity and, in a second activity level state, the CBS therapy is delivered at a second intensity different than the first intensity. 2. The method according to claim 1 , further comprising: detecting subcutaneous electrocardiographic (ECG) signals; and determining, based on the ECG signals, a change in a heart rate in response to the CBS therapy. 3. The method according to claim 1 , wherein: determining the activity level of the patient comprises estimating when the patient is in a sleep state based on the sensed blood pressure of the patient; and the set of parameters of the CBS therapy are modified from the first intensity to the second intensity when the patient is estimated to be in the sleep state. 4. The method according to claim 1 , wherein the CBS electrode assembly is electrically coupled to the carotid baroreceptors. 5. The method according to claim 4 , wherein the single cuff structure is configured to wrap around a carotid artery. 6. The method according to claim 1 , wherein the CBS electrode assembly is a first CBS electrode assembly, and wherein: delivering the CBS therapy comprises delivering electrical stimulation via the first CBS electrode assembly electrically coupled to a first carotid baroreceptor region and delivering electrical stimulation via a second CBS electrode assembly electrically coupled to a second baroreceptor region. 7. The method according to claim 1 , wherein the CBS electrode assembly is a first CBS electrode assembly and delivering the CBS therapy comprises: delivering electrical stimulation via the first CBS electrode assembly electrically coupled to a first carotid baroreceptor region and provided at a distal end of a first CBS lead portion; and delivering electrical stimulation via a second CBS electrode assembly electrically coupled to a second carotid baroreceptor region and provided at a distal end of a second CBS lead portion, the first CBS lead portion and the second CBS lead portion coupled to a bifurcated portion of a lead assembly. 8. The method according to claim 1 , wherein the CBS electrode assembly is a first CBS electrode assembly and delivering the CBS therapy comprises: delivering electrical stimulation via the first CBS electrode assembly electrically coupled to a first carotid baroreceptor region and provided at a distal end of a first CBS lead portion, the first CBS lead portion coupled to a bifurcated portion of a first lead assembly; and delivering electrical stimulation via a second CBS electrode assembly electrically coupled to a second carotid baroreceptor region and provided at a distal end of a second CBS lead portion, the second CBS lead portion coupled to a bifurcated portion of a second lead assembly. 9. The method according to claim 1 , further comprising: delivering a vagus nerve stimulation (VNS) therapy to a vagus nerve of the patient for the treatment of chronic heart failure, according to a second set of parameters, with the pulse generator. 10. The method according to claim 9 , wherein at least a portion of the CBS therapy is provided during a same time during which at least a portion of the VNS therapy is provided. 11. A non-transitory computer-readable medium having instructions stored thereon that are executable by a processor of an implantable neurostimulation system to cause the processor to perform operations comprising: delivering a carotid baroreceptor stimulation (CBS) therapy to carotid baroreceptors of a patient, according to a set of parameters, with a pulse generator via a CBS electrode assembly having at least one CBS electrode contact and an integrated pressure sensor configured to sense a blood pressure of the patient, the at least one CBS electrode contact and the integrated pressure sensor integrated into a single cuff structure; determining an activity level of the patient based on the sensed blood pressure of the patient; and modifying the set of parameters of the CBS therapy based on the determined activity level, wherein, in a first activity level state, the CBS therapy is delivered at a first intensity and, in a second activity level state, the CBS therapy is delivered at a second intensity different than the first intensity. 12. The non-transitory computer-readable medium of claim 11 , wherein the operations further comprise: detecting subcutaneous electrocardiographic (ECG) signals; and determining, based on the ECG signals, a change in a heart rate in response to the CBS therapy. 13. The non-transitory computer-readable medium of claim 11 , wherein: determining the activity level of the patient comprises estimating when the patient is in a sleep state based on the sensed blood pressure of the patient; and the set of parameters of the CBS therapy are modified from the first intensity to the second intensity when the patient is estimated to be in the sleep state. 14. The non-transitory computer-readable medium of claim 11 , wherein delivering the CBS therapy comprises delivering bilateral CBS therapy to a first baroreceptor region and a second baroreceptor region. 15. The non-transitory computer-readable medium of claim 11 , wherein the CBS electrode assembly is electrically coupled to the carotid baroreceptors. 16. The non-transitory computer-readable medium of claim 15 , wherein the single cuff structure is configured to wrap around a carotid artery. 17. The non-transitory computer-readable medium of claim 11 , wherein the CBS electrode assembly is a first CBS electrode assembly and delivering the CBS therapy comprises delivering electrical stimulation via the first CBS electrode assembly electrically coupled to a first carotid baroreceptor region and delivering electrical stimulation via a second CBS electrode assembly electrically coupled to a second baroreceptor region. 18. The non-transitory computer-readable medium of claim 11 , wherein the operations further comprise: delivering a vagus nerve stimulation (VNS) therapy to a vagus nerve of the patient, according to a second set of parameters, with the pulse generator. 19. The non-transitory computer-readable medium of claim 18 , wherein at least a portion of the CBS therapy is provided during a same time during which at least a portion of the VNS therapy is provided.

Assignees

Inventors

Classifications

  • specified by the stimulation parameters · CPC title

  • adapted for stimulating afferent nerves · CPC title

  • Cardiac control, e.g. by vagal stimulation (stimulating the heart A61N1/362) · CPC title

  • with automatic adjustment · CPC title

  • Spinal or peripheral nerve electrodes · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US11918812B2 cover?
Systems and methods are provided for delivering vagus nerve stimulation and carotid baroreceptor stimulation to patients for treating chronic heart failure and hypertension. The vagus nerve stimulation and carotid baroreceptor stimulation therapies may be provided using a single implantable pulse generator, which can coordinate delivery of the therapies.
Who is the assignee on this patent?
Livanova Usa Inc
What technology area does this patent fall under?
Primary CPC classification A61N1/36146. Mapped technology areas include Human Necessities.
When was this patent published?
Publication date Tue Mar 05 2024 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 6 related publications on this page (citations in our corpus or others sharing the same primary CPC).